# Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients

> **NCT04454307** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tanta University** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Tramadol
- **OTHER:** Standard care delivered in the isolation hospitals.

## Key facts

- **NCT ID:** NCT04454307
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07
- **Primary completion:** 2020-08
- **Final completion:** 2020-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454307, "Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04454307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*